Pathologic outcomes in favorable-risk prostate cancer: Comparative analysis of men electing active surveillance and immediate surgery

European Urology

Volumn 69, Issue 4, 2016, Pages 576-581

  Tosoian, Jeffrey J ^a   Sundi, Debasish ^a   Trock, Bruce J ^a,b,c   Landis, Patricia ^a   Epstein, Jonathan I ^a,c   Schaeffer, Edward M ^a,c   Carter, H Ballentine ^a,c   Mamawala, Mufaddal ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Active surveillance; Oncologic outcomes; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; KALLIKREIN; KALLIKREIN-RELATED PEPTIDASE 3, HUMAN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER PATIENT; CANCER RISK; CANCER STAGING; CANCER SURGERY; COMPARATIVE STUDY; DELAYED PROSTATECTOMY AFTER SURVEILLANCE; DIGITAL RECTAL EXAMINATION; FAVORABLE RISK PROSTATE CANCER; FOLLOW UP; GLEASON SCORE; HEALTH PROGRAM; HUMAN; HUMAN TISSUE; IMMEDIATE PROSTATECTOMY; LOW RISK PATIENT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SURGICAL PATIENT; ADVERSE EFFECTS; BLOOD; CANCER GRADING; CHI SQUARE DISTRIBUTION; ELECTIVE SURGERY; LYMPH NODE METASTASIS; MARYLAND; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATHOLOGY; PATIENT SELECTION; PROSTATIC NEOPLASMS; REGISTER; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; TIME FACTOR; TIME TO TREATMENT; TREATMENT OUTCOME; TUMOR INVASION; VERY ELDERLY; WATCHFUL WAITING;

ADULT; AGED; AGED, 80 AND OVER; BALTIMORE; CHI-SQUARE DISTRIBUTION; ELECTIVE SURGICAL PROCEDURES; HUMANS; KALLIKREINS; LOGISTIC MODELS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; NEOPLASM INVASIVENESS; ODDS RATIO; PATIENT SELECTION; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TIME-TO-TREATMENT; TREATMENT OUTCOME; WATCHFUL WAITING;

EID: 84959313687     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2015.09.032     Document Type: Article

References (26)

1. M.G. Sanda, R.L. Dunn, J. Michalski, and et al. Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250 1261
2. R.K. Nam, P. Cheung, S. Herschorn, and et al. Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study Lancet Oncol 15 2014 223 231
3. S. Loeb, M.A. Bjurlin, J. Nicholson, and et al. Overdiagnosis and overtreatment of prostate cancer Eur Urol 65 2014 1046 1055
4. T.J. Daskivich, K.H. Fan, T. Koyama, and et al. Prediction of long-term other-cause mortality in men with early-stage prostate cancer: results from the Prostate Cancer Outcomes Study Urology 85 2015 92 100
5. M.R. Cooperberg, P.R. Carroll, and L. Klotz Active surveillance for prostate cancer: progress and promise J Clin Oncol 29 2011 3669 3676
6. M.R. Cooperberg, and P.R. Carroll Trends in management for patients with localized prostate cancer, 1990-2013 JAMA 314 2015 80 82
7. S. Loeb, Y. Folkvaljon, D.V. Makarov, O. Bratt, A. Bill-Axelson, and P. Stattin Five-year nationwide follow-up study of active surveillance for prostate cancer Eur Urol 67 2015 233 238
8. P.R. Womble, J.E. Montie, Z. Ye, and et al. Contemporary use of initial active surveillance among men in Michigan with low-risk prostate cancer Eur Urol 67 2015 44 50
9. G.S. Sandhu, and G.L. Andriole Active surveillance for prostate cancer: barriers to widespread adoption Eur Urol 62 2012 984 985
10. M. Popiolek, J.R. Rider, O. Andren, and et al. Natural history of early, localized prostate cancer: a final report from three decades of follow-up Eur Urol 63 2013 428 435
11. M.A. Dall'Era, P.C. Albertsen, C. Bangma, and et al. Active surveillance for prostate cancer: a systematic review of the literature Eur Urol 62 2012 976 983
12. J.A. Lane, J.L. Donovan, M. Davis, and et al. Active monitoring, radical prostatectomy, or radiotherapy for localised prostate cancer: study design and diagnostic and baseline results of the ProtecT randomised phase 3 trial Lancet Oncol 15 2014 1109 1118
13. C. Warlick, B.J. Trock, P. Landis, J.I. Epstein, and H.B. Carter Delayed versus immediate surgical intervention and prostate cancer outcome J Natl Cancer Inst 98 2006 355 357
14. R.C. van den Bergh, E.W. Steyerberg, A. Khatami, and et al. Is delayed radical prostatectomy in men with low-risk screen-detected prostate cancer associated with a higher risk of unfavorable outcomes? Cancer 116 2010 1281 1290
15. R. Satkunasivam, G.S. Kulkarni, A.R. Zlotta, and et al. Pathological, oncologic and functional outcomes of radical prostatectomy following active surveillance J Urol 190 2013 91 95
16. A.A. Hussein, C.J. Welty, N. Ameli, and et al. Untreated Gleason grade progression on serial biopsies during prostate cancer active surveillance: clinical course and pathological outcomes J Urol 194 2015 85 90
17. J.J. Tosoian, M. Mamawala, J.I. Epstein, and et al. Intermediate and longer-term outcomes from a prospective active-surveillance program for favorable-risk prostate cancer J Clin Oncol 33 2015 3379 3385
18. M.H. Umbehr, E.A. Platz, S.B. Peskoe, and et al. Serum prostate-specific antigen (PSA) concentration is positively associated with rate of disease reclassification on subsequent active surveillance prostate biopsy in men with low PSA density BJU Int 113 2014 561 567
19. J.J. Tosoian, B.J. Trock, P. Landis, and et al. Active surveillance program for prostate cancer: an update of the Johns Hopkins experience J Clin Oncol 29 2011 2185 2190
20. A.E. Ross, S. Loeb, P. Landis, and et al. Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program J Clin Oncol 28 2010 2810 2816
21. H.D. Patel, E. Humphreys, B.J. Trock, M. Han, and H.B. Carter Practice patterns and individual variability of surgeons performing radical prostatectomy at a high volume academic center J Urol 193 2015 812 819
22. S.E. Eggener, P.T. Scardino, P.C. Walsh, and et al. Predicting 15-year prostate cancer specific mortality after radical prostatectomy J Urol 185 2011 869 875
23. P. Peduzzi, J. Concato, E. Kemper, T.R. Holford, and A.R. Feinstein A simulation study of the number of events per variable in logistic regression analysis J Clin Epidemiol 49 1996 1373 1379
24. V. Iremashvili, M. Manoharan, D.L. Rosenberg, K. Acosta, and M.S. Soloway Pathological findings at radical prostatectomy in patients initially managed by active surveillance: a comparative analysis Prostate 72 2012 1573 1579
25. P. Filippou, C.J. Welty, J.E. Cowan, N. Perez, K. Shinohara, and P.R. Carroll Immediate versus delayed radical prostatectomy: updated outcomes following active surveillance of prostate cancer Eur Urol 68 2015 458 463
26. D. Stacey, F. Legare, N.F. Col, and et al. Decision aids for people facing health treatment or screening decisions Cochrane Database Syst Rev 2014 CD001431